- No file added yet -

Dupilumab Maintains Long-Term Disease Control in Adults With Moderate to Severe Atopic Dermatitis as Measured by Well-Controlled Weeks: Results From the LIBERTY AD CHRONOS Clinical Trial

media

posted on 2021-01-22, 09:53 authored by Adis journals on behalf of, Jashin J. Wu, Lynda Spelman, Jerry L. Tan, Takafumi Etoh, Haixin Zhang, Brad Shumel, Ana B. Rossi

Article full text

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).